Is the choice of the statistical model relevant in the cost estimation of patients with chronic diseases? An empirical approach by the Piedmont Diabetes Registry

BMC Health Services Research

Volumn 15, Issue 1, 2015, Pages

  Pagano, Eva ^a   Petrelli, Alessio ^b,c   Picariello, Roberta ^b   Merletti, Franco ^a,d   Gnavi, Roberto ^b   Bruno, Graziella ^d  

^a CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^b ASL 5   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

Author keywords

Chronic diseases; Diabetes Mellitus; Lifetime costs; Modeling techniques

Indexed keywords

ADULT; AGED; CHRONIC DISEASE; DECISION MAKING; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ECONOMICS; FEMALE; HEALTH CARE COST; HUMAN; MALE; MIDDLE AGED; REGISTER; STATISTICAL MODEL;

ADULT; AGED; CHOICE BEHAVIOR; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; REGISTRIES;

EID: 84952026839     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/s12913-015-1241-1     Document Type: Article

References (32)

1. International Diabetes Federation. The Diabetes Atlas. Fourth Edition. Brussels: International Diabetes Federation; 2009. http://www.idf.org/diabetesatlas. Accessed 24 Dec 2015.
2. Muka T, Imo D, Jaspers L, Colpani V, Chaker L, van der Lee SJ, et al. The global impact of non-communicable diseases on healthcare spending and national income: a systematic review. Eur J Epidemiol. 2015;30:251-77.
3. Gregori D, Petrinco M, Bo S, Desideri A, Merletti F, Pagano E. Regression models for analyzing costs and their determinants in health care: an introductory review. Int J Qual Health Care. 2011;23:331-41.
4. Gray AM, Clarke PM, Wolstenholme JL, Wordsworth S. Analysing Costs. Applied Methods fo Cost-effectiveness Analysis in Health Care. Oxford: Oxford University Press; 2011.
5. Duan N, Manning WG, Morris CN, Newhouse JP. A comparison of alternative models for the demand for medical care. J Bus Econ Stat. 1983;1:115-26.
6. Tian L, Huang J. A two-part model for censored medical cost data. Stat Med. 2007;26:4273-92.
7. Basu A, Manning WG. Estimating lifetime or episode-of-illness costs under censoring. Health Econ. 2010;19:1010-28.
8. Young TA. Estimating mean total costs in the presence of censoring: a comparative assessment of methods. Pharmacoeconomics. 2005;23:1229-42.
9. Grieve R, Nixon R, Thompson SG, Normand C. Using multilevel models for assessing the variability of multinational resource use and cost data. Health Econ. 2005;14:185-96.
10. Manca A, Rice N, Sculpher MJ, Briggs AH. Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models. Health Econ. 2005;14:471-85.
11. Nixon RM, Thompson SG. Methods for incorporating covariate adjustment, subgroup analysis and between-centre differences into cost-effectiveness evaluations. Health Econ. 2005;14:1217-29.
12. Jones A. Models for health care. The University of York, HEDG Working Paper 10/01. https://www.york.ac.uk/media/economics/documents/herc/wp/10-01.pdf. Accessed 24 Dec 2015.
13. Mihaylova B, Briggs A, O'Hagan A, Thompson SG. Review of statistical methods for analysing healthcare resources and costs. Health Econ. 2011;20:897-916.
14. Bruno G, Picariello R, Petrelli A, Panero F, Costa G, Cavallo-Perin P, et al. Direct costs in diabetic and non diabetic people: the population-based Turin study, Italy. Nutr Metab Cardiovasc Dis. 2012;22:684-90.
15. Gnavi R, Karaghiosoff L, Costa G, Merletti F, Bruno G. Socio-economic differences in the prevalence of diabetes in Italy: the population-based Turin study. Nutr Metab Cardiovasc Dis. 2008;18:678-82.
16. Manning WG. The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ. 1998;17:283-95.
17. Duan N. Smearing estimate: a non parametric retransformation method. J Am Stat Assoc. 1983;78:605-10.
18. McCullagh P. Generalized linear models. Eur J Oper Res. 1984;16:285-92.
19. Madsen H, Thyregod P. Introduction to General and Generalized Linear Models: CRC Press. 2010.
20. Diehr P, Yanez D, Ash A, Hornbrook M, Lin DY. Methods for analyzing health care utilization and costs. Annu Rev Public Health. 1999;20:125-44.
21. Cole SR. Simple bootstrap statistical inference using the SAS system. Comput Methods Programs Biomed. 1999;60:79-82.
22. Palmer AJ, Mount Hood 5 Modeling G, Clarke P, Gray A, Leal J, Lloyd A, et al. Computer modeling of diabetes and its complications: a report on the Fifth Mount Hood challenge meeting. Value Health. 2013;16:670-85.
23. Baumeister SE, Boger CA, Kramer BK, Doring A, Eheberg D, Fischer B, et al. Effect of chronic kidney disease and comorbid conditions on health care costs: A 10-year observational study in a general population. Am J Nephrol. 2010;31:222-9.
24. Icks A, Claessen H, Strassburger K, Tepel M, Waldeyer R, Chernyak N, et al. Drug costs in prediabetes and undetected diabetes compared with diagnosed diabetes and normal glucose tolerance: results from the population-based KORA Survey in Germany. Diabetes Care. 2013;36:e53-4.
25. Li R, Bilik D, Brown MB, Zhang P, Ettner SL, Ackermann RT, et al. Medical costs associated with type 2 diabetes complications and comorbidities. Am J Manag Care. 2013;19:421-30.
26. Shi L, Ye X, Lu M, Wu EQ, Sharma H, Thomason D, et al. Clinical and economic benefits associated with the achievement of both HbA1c and LDL cholesterol goals in veterans with type 2 diabetes mellitus. Diabetes Care. 2013.
27. Egede LE, Gebregziabher M, Dismuke CE, Lynch CP, Axon RN, Zhao Y, et al. Medication nonadherence in diabetes: longitudinal effects on costs and potential cost savings from improvement. Diabetes Care. 2012;35:2533-9.
28. Kilian R, Matschinger H, Loeffler W, Roick C, Angermeyer MC. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment. J Ment Health Policy Econ. 2002;5:21-31.
29. Gregori D, Desideri A, Bigi R, Petrinco M, Cortigiani L, Zigon G, et al. Proper modeling strategies selection for the assessment of post-infarction costs. Int J Cardiol. 2008;129:53-8.
30. Griswold M, Parmigiani G, Potosky A, Lipscomb J. Analyzing health care costs: a comparison of statistical methods motivated by Maedicare colorectal cancer charges. Biostatistics. 2004;1:1-23.
31. Dudley RA, Harrell Jr FE, Smith LR, Mark DB, Califf RM, Pryor DB, et al. Comparison of analytic models for estimating the effect of clinical factors on the cost of coronary artery bypass graft surgery. J Clin Epidemiol. 1993;46:261-71.
32. Lipscomb J, Ancukiewicz M, Parmigiani G, Hasselblad V, Samsa G, Matchar DB. Predicting the cost of illness: a comparison of alternative models applied to stroke. Med Decis Making. 1998;18:S39-56.